Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Bolt Biotherapeutics, Inc. (BOLT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2023 4 Yonehiro Grant (Chief Business Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 228,000 options to buy @ $1.59, valued at $362.5k
02/28/2023 4 Schatzman Randall C (CEO) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 728,270 options to buy @ $1.59, valued at $1.2M
02/28/2023 4 Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 250,000 options to buy @ $1.59, valued at $397.5k
02/28/2023 4 Quinn William P. (CFO) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 250,000 options to buy @ $1.59, valued at $397.5k
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.99, valued at $49.8k
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2022 4 O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 22,140 options to buy @ $3.03, valued at $67.1k
Granted 14,071 options to buy @ $3.03, valued at $42.6k
03/28/2022 4 LAPORTE KATHLEEN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.03, valued at $75.8k
03/28/2022 4 Lee Frank D. (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 22,140 options to buy @ $3.03, valued at $67.1k
Granted 14,071 options to buy @ $3.03, valued at $42.6k
03/28/2022 4 ENGLEMAN EDGAR (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.03, valued at $75.8k
03/28/2022 4 ONETTO NICOLE (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 22,140 options to buy @ $3.03, valued at $67.1k
Granted 12,227 options to buy @ $3.03, valued at $37k
03/28/2022 4 MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.03, valued at $75.8k
03/28/2022 4 SHAH MAHENDRA (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.03, valued at $75.8k
03/28/2022 4 HEALY JAMES (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 25,000 options to buy @ $3.03, valued at $75.8k
02/23/2022 4 Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 210,000 options to buy @ $3.08, valued at $646.8k
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Quinn William P. (CFO) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 210,000 options to buy @ $3.08, valued at $646.8k
02/23/2022 4 Dornan David (Chief Scientific Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Granted 210,000 options to buy @ $3.08, valued at $646.8k
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.
Txns: Bought 917 shares @ $16.65, valued at $15.3k
Bought 411 shares @ $4.64, valued at $1.9k
Exercised 35,714 options to buy @ $2.8, valued at $100k
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
12/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy